Pre-order Enquiry
Request Free Sample
Global Psoriasis Therapeutics Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application
SKU ID : QYR-14083355 | Publishing Date : 11-Apr-2019 | No. of pages : 94
Detailed TOC of Global Psoriasis Therapeutics Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application
Table of ContentsPsoriasis Therapeutics Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Psoriasis Therapeutics
1.1 Psoriasis Therapeutics Market Overview
1.1.1 Psoriasis Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Psoriasis Therapeutics Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Psoriasis Therapeutics Market by Type
1.3.1 TNF Inhibitors
1.3.2 PDE4 Inhibitors
1.3.3 Interleukin Blockers
1.3.4 Others
1.4 Psoriasis Therapeutics Market by End Users/Application
1.4.1 Oral
1.4.2 Parenteral
1.4.3 Topical
2 Global Psoriasis Therapeutics Competition Analysis by Players
2.1 Psoriasis Therapeutics Market Size (Value) by Players (2018 and 2019)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Astellas Pharma Inc.
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Psoriasis Therapeutics Revenue (Value) (2014-2019)
3.1.5 Recent Developments
3.2 AstraZeneca plc
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Psoriasis Therapeutics Revenue (Value) (2014-2019)
3.2.5 Recent Developments
3.3 Boehringer Ingelheim GmbH
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Psoriasis Therapeutics Revenue (Value) (2014-2019)
3.3.5 Recent Developments
3.4 F. Hofffmann-La Roche
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Psoriasis Therapeutics Revenue (Value) (2014-2019)
3.4.5 Recent Developments
3.5 GlaxoSmithKline plc
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Psoriasis Therapeutics Revenue (Value) (2014-2019)
3.5.5 Recent Developments
3.6 Merck & Co., Inc.
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Psoriasis Therapeutics Revenue (Value) (2014-2019)
3.6.5 Recent Developments
3.7 Valeant Pharmaceuticals International, Inc.
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Psoriasis Therapeutics Revenue (Value) (2014-2019)
3.7.5 Recent Developments
3.8 Biocon Limited
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Psoriasis Therapeutics Revenue (Value) (2014-2019)
3.8.5 Recent Developments
3.9 Eli Lilly and Company
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Psoriasis Therapeutics Revenue (Value) (2014-2019)
3.9.5 Recent Developments
3.10 G & W Laboratories Inc.
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Psoriasis Therapeutics Revenue (Value) (2014-2019)
3.10.5 Recent Developments
4 Global Psoriasis Therapeutics Market Size by Type and Application (2014-2019)
4.1 Global Psoriasis Therapeutics Market Size by Type (2014-2019)
4.2 Global Psoriasis Therapeutics Market Size by Application (2014-2019)
4.3 Potential Application of Psoriasis Therapeutics in Future
4.4 Top Consumer/End Users of Psoriasis Therapeutics
5 North America Psoriasis Therapeutics Development Status and Outlook
5.1 North America Psoriasis Therapeutics Market Size (2014-2019)
5.2 North America Psoriasis Therapeutics Market Size and Market Share by Players (2018 and 2019)
6 Europe Psoriasis Therapeutics Development Status and Outlook
6.1 Europe Psoriasis Therapeutics Market Size (2014-2019)
6.2 Europe Psoriasis Therapeutics Market Size and Market Share by Players (2018 and 2019)
7 China Psoriasis Therapeutics Development Status and Outlook
7.1 China Psoriasis Therapeutics Market Size (2014-2019)
7.2 China Psoriasis Therapeutics Market Size and Market Share by Players (2018 and 2019)
8 Rest of Asia Pacific Psoriasis Therapeutics Development Status and Outlook
8.1 Rest of Asia Pacific Psoriasis Therapeutics Market Size (2014-2019)
8.2 Rest of Asia Pacific Psoriasis Therapeutics Market Size and Market Share by Players (2018 and 2019)
9 Central & South America Psoriasis Therapeutics Development Status and Outlook
9.1 Central & South America Psoriasis Therapeutics Market Size (2014-2019)
9.2 Central & South America Psoriasis Therapeutics Market Size and Market Share by Players (2018 and 2019)
10 Middle East & Africa Psoriasis Therapeutics Development Status and Outlook
10.1 Middle East & Africa Psoriasis Therapeutics Market Size (2014-2019)
10.2 Middle East & Africa Psoriasis Therapeutics Market Size and Market Share by Players (2018 and 2019)
11 Market Forecast by Regions, Type and Application (2019-2025)
11.1 Global Psoriasis Therapeutics Market Size (Value) by Regions (2019-2025)
11.1.1 North America Psoriasis Therapeutics Revenue and Growth Rate (2019-2025)
11.1.2 Europe Psoriasis Therapeutics Revenue and Growth Rate (2019-2025)
11.1.3 China Psoriasis Therapeutics Revenue and Growth Rate (2019-2025)
11.1.4 Rest of Asia Pacific Psoriasis Therapeutics Revenue and Growth Rate (2019-2025)
11.1.5 Central & South America Psoriasis Therapeutics Revenue and Growth Rate (2019-2025)
11.1.6 Middle East & Africa Psoriasis Therapeutics Revenue and Growth Rate (2019-2025)
11.2 Global Psoriasis Therapeutics Market Size (Value) by Type (2019-2025)
11.3 Global Psoriasis Therapeutics Market Size by Application (2019-2025)
12 Psoriasis Therapeutics Market Dynamics
12.1 Psoriasis Therapeutics Market Opportunities
12.2 Psoriasis Therapeutics Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Psoriasis Therapeutics Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Psoriasis Therapeutics Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
List of Figures, Tables and Charts Available in Global Psoriasis Therapeutics Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application
List of Tables and FiguresFigure Psoriasis Therapeutics Product Scope
Figure Global Psoriasis Therapeutics Market Size (Million USD) (2014-2019)
Table Global Psoriasis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Global Psoriasis Therapeutics Market Share by Regions in 2018
Figure North America Psoriasis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Europe Psoriasis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure China Psoriasis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Rest of Asia Pacific Psoriasis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Central & South America Psoriasis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Middle East & Africa Psoriasis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Figure Global Psoriasis Therapeutics Market Share by Type in 2018
Figure TNF Inhibitors Market Size (Million USD) and Growth Rate (2014-2019)
Figure PDE4 Inhibitors Market Size (Million USD) and Growth Rate (2014-2019)
Figure Interleukin Blockers Market Size (Million USD) and Growth Rate (2014-2019)
Figure Others Market Size (Million USD) and Growth Rate (2014-2019)
Figure Global Psoriasis Therapeutics Market Share by Application in 2018
Table Key Downstream Customer in Oral
Figure Psoriasis Therapeutics Market Size (Million USD) and Growth Rate in Oral (2014-2019)
Table Key Downstream Customer in Parenteral
Figure Psoriasis Therapeutics Market Size (Million USD) and Growth Rate in Parenteral (2014-2019)
Table Key Downstream Customer in Topical
Figure Psoriasis Therapeutics Market Size (Million USD) and Growth Rate in Topical (2014-2019)
Table Psoriasis Therapeutics Market Size (Million USD) by Players (2018 and 2019)
Figure Psoriasis Therapeutics Market Size Share by Players in 2018
Figure Psoriasis Therapeutics Market Size Share by Players in 2019
Table Astellas Pharma Inc. Basic Information List
Table Psoriasis Therapeutics Business Revenue (Million USD) of Astellas Pharma Inc. (2014-2019)
Figure Astellas Pharma Inc. Psoriasis Therapeutics Business Revenue Market Share in 2018
Table AstraZeneca plc Basic Information List
Table Psoriasis Therapeutics Business Revenue (Million USD) of AstraZeneca plc (2014-2019)
Figure AstraZeneca plc Psoriasis Therapeutics Business Revenue Market Share in 2018
Table Boehringer Ingelheim GmbH Basic Information List
Table Psoriasis Therapeutics Business Revenue (Million USD) of Boehringer Ingelheim GmbH (2014-2019)
Figure Boehringer Ingelheim GmbH Psoriasis Therapeutics Business Revenue Market Share in 2018
Table F. Hofffmann-La Roche Basic Information List
Table Psoriasis Therapeutics Business Revenue (Million USD) of F. Hofffmann-La Roche (2014-2019)
Figure F. Hofffmann-La Roche Psoriasis Therapeutics Business Revenue Market Share in 2018
Table GlaxoSmithKline plc Basic Information List
Table Psoriasis Therapeutics Business Revenue (Million USD) of GlaxoSmithKline plc (2014-2019)
Figure GlaxoSmithKline plc Psoriasis Therapeutics Business Revenue Market Share in 2018
Table Merck & Co., Inc. Basic Information List
Table Psoriasis Therapeutics Business Revenue (Million USD) of Merck & Co., Inc. (2014-2019)
Figure Merck & Co., Inc. Psoriasis Therapeutics Business Revenue Market Share in 2018
Table Valeant Pharmaceuticals International, Inc. Basic Information List
Table Psoriasis Therapeutics Business Revenue (Million USD) of Valeant Pharmaceuticals International, Inc. (2014-2019)
Figure Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Business Revenue Market Share in 2018
Table Biocon Limited Basic Information List
Table Psoriasis Therapeutics Business Revenue (Million USD) of Biocon Limited (2014-2019)
Figure Biocon Limited Psoriasis Therapeutics Business Revenue Market Share in 2018
Table Eli Lilly and Company Basic Information List
Table Psoriasis Therapeutics Business Revenue (Million USD) of Eli Lilly and Company (2014-2019)
Figure Eli Lilly and Company Psoriasis Therapeutics Business Revenue Market Share in 20187
Table G & W Laboratories Inc. Basic Information List
Table Psoriasis Therapeutics Business Revenue (Million USD) of G & W Laboratories Inc. (2014-2019)
Figure G & W Laboratories Inc. Psoriasis Therapeutics Business Revenue Market Share in 2018
Table Global Psoriasis Therapeutics Market Size (Million USD) by Type (2014-2019)
Figure Global Psoriasis Therapeutics Market Size Share by Type in 2014
Figure Global Psoriasis Therapeutics Market Size Share by Type in 2015
Figure Global Psoriasis Therapeutics Market Size Share by Type in 2016
Figure Global Psoriasis Therapeutics Market Size Share by Type in 2017
Figure Global Psoriasis Therapeutics Market Size Share by Type in 2018
Figure Global Psoriasis Therapeutics Market Size Share by Type in 2019
Table Global Psoriasis Therapeutics Market Size (Million USD) by Application (2014-2019)
Figure Global Psoriasis Therapeutics Market Size (Million USD) by Application in 2014
Figure Global Psoriasis Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Psoriasis Therapeutics Market Size (Million USD) by Application in 2015
Figure Global Psoriasis Therapeutics Market Size (Million USD) by Application in 2017
Figure Global Psoriasis Therapeutics Market Size (Million USD) by Application in 2018
Figure Global Psoriasis Therapeutics Market Size (Million USD) by Application in 2019
Table Top Consumer/End Users of Psoriasis Therapeutics
Figure North America Psoriasis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table North America Psoriasis Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure North America Psoriasis Therapeutics Market Size Share by Players in 2018
Figure North America Psoriasis Therapeutics Market Size Share by Players in 2019
Figure Europe Psoriasis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Europe Psoriasis Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Europe Psoriasis Therapeutics Market Size Share by Players in 2018
Figure Europe Psoriasis Therapeutics Market Size Share by Players in 2019
Figure China Psoriasis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table China Psoriasis Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure China Psoriasis Therapeutics Market Size Share by Players in 2018
Figure China Psoriasis Therapeutics Market Size Share by Players in 2019
Figure Rest of Asia Pacific Psoriasis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Rest of Asia Pacific Psoriasis Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Rest of Asia Pacific Psoriasis Therapeutics Market Size Share by Players in 2018
Figure Rest of Asia Pacific Psoriasis Therapeutics Market Size Share by Players in 2019
Figure Central & South America Psoriasis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Central & South America Psoriasis Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Central & South America Psoriasis Therapeutics Market Size Share by Players in 2018
Figure Central & South America Psoriasis Therapeutics Market Size Share by Players in 2019
Figure Middle East & Africa Psoriasis Therapeutics Market Size (Million USD) and Growth Rate by Regions (2014-2019)
Table Middle East & Africa Psoriasis Therapeutics Market Size (Million USD) by Players (2014-2019)
Figure Middle East & Africa Psoriasis Therapeutics Market Size Share by Players in 2018
Figure Middle East & Africa Psoriasis Therapeutics Market Size Share by Players in 2019
Figure Global Psoriasis Therapeutics Market Size (Million USD) by Regions (2019-2025)
Table Global Psoriasis Therapeutics Market Size (Million USD) by Regions (2019-2025)
Figure Global Psoriasis Therapeutics Market Size Share by Regions in 2019
Figure Global Psoriasis Therapeutics Market Size Share by Regions in 2025
Figure North America Psoriasis Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Europe Psoriasis Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure China Psoriasis Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Rest of Asia Pacific Psoriasis Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Central & South America Psoriasis Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Figure Middle East & Africa Psoriasis Therapeutics Revenue (Million USD) and Growth Rate (2019-2025)
Table Global Psoriasis Therapeutics Market Size (Million USD) by Type (2019-2025)
Figure Global Psoriasis Therapeutics Market Size Share by Type in 2019
Figure Global Psoriasis Therapeutics Market Size Share by Type in 2025
Table Global Psoriasis Therapeutics Market Size (Million USD) by Application (2019-2025)
Figure Global Psoriasis Therapeutics Market Size (Million USD) by Application in 2019
Figure Global Psoriasis Therapeutics Market Size (Million USD) by Application in 2025
Keyplayers in Global Psoriasis Therapeutics Market Report, History and Forecast 2014-2025, Breakdown Data by Companies, Key Regions, Types and Application
Astellas Pharma Inc.AstraZeneca plc
Boehringer Ingelheim GmbH
F. Hofffmann-La Roche
GlaxoSmithKline plc
Merck & Co., Inc.
Valeant Pharmaceuticals International, Inc.
Biocon Limited
Eli Lilly and Company
G & W Laboratories Inc.
Request Sample
Request Discount
